RC148 (Dose 1) plus Capecitabine and Oxaliplatin Clinical Trials

1 actively recruiting trial

Also known as: RC148 (Dose 1) plus CAPEOX

Pipeline

Phase 2/3: 1

Top Sponsors

RemeGen Co., Ltd.1

Indications

Colorectal (Colon or Rectal) Cancer1
Cancer1

Other1 trial

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.